Company intelligence / Profile preview

Colpman Consulting

Abingdon, Oxfordshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

Colpman Consulting is a specialist strategic advisory firm providing business development and corporate strategy services to the global life sciences industry. Led by Dr. David Colpman, the firm leverages extensive experience in licensing, mergers and acquisitions, and portfolio management to support biotech and pharmaceutical clients. Their services include asset scouting, commercial due diligence, and negotiation support for complex cross-border transactions. The consultancy is particularly recognized for its expertise in navigating the transition from R&D to commercial-stage operations and has a strong track record in high-value deal-making.

Industry: Consulting

Beyond the preview

Go deeper on Colpman Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colpman Consulting.

Explore the full profile